Early research (Phase 1)Study completedNCT04612062What this trial is testingA First-in-Human Study of CEE321 in Adult SubjectsWho this might be right forAtopic Dermatitis Novartis Pharmaceuticals 28
Early research (Phase 1)Ended earlyNCT04211415What this trial is testingPhase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic DermatitisWho this might be right forAtopic Dermatitis Daiichi Sankyo Co., Ltd. 8
Early research (Phase 1)Study completedNCT01423656What this trial is testingSafety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102Who this might be right forAtopic Dermatitis LEO Pharma 102
Early research (Phase 1)Study completedNCT00891709What this trial is testingLEO 29102 Single and Multiple Dose Study by Dermal ApplicationWho this might be right forAtopic Dermatitis LEO Pharma 64
Not applicableStudy completedNCT02125695What this trial is testingPilot Tape Harvesting StudyWho this might be right forAtopic DermatitisHealthyDiscoid Lupus Erythematosus+1 more Biogen 37
Early research (Phase 1)Study completedNCT01614756What this trial is testingA Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic DermatitisWho this might be right forHealthy Subjects and Atopic Dermatitis Subjects Bristol-Myers Squibb 93
Early research (Phase 1)Study completedNCT02345928What this trial is testingA Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic DermatitisWho this might be right forAsthmaAtopic DermatitisHealthy Janssen Research & Development, LLC 108
Early research (Phase 1)Ended earlyNCT05382819What this trial is testingA Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis Eczema Fresh Tracks Therapeutics, Inc. 89
Early research (Phase 1)Study completedNCT06614907What this trial is testingA PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent®Who this might be right forAtopic Dermatitis Qilu Pharmaceutical Co., Ltd. 198
Early research (Phase 1)Study completedNCT06268860What this trial is testingAssess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy ParticipantsWho this might be right forAtopic Dermatitis Amgen 240
Early research (Phase 1)Study completedNCT02148744What this trial is testingSafety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic DermatitisWho this might be right forAllergic RhinitisAllergic ConjunctivitisAtopic Dermatitis Xencor, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT02795832What this trial is testingDetermine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis Ziarco Pharma Ltd 53
Early research (Phase 1)Study completedNCT07103369What this trial is testingA Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis SinoMab BioScience Ltd 64
Early research (Phase 1)Study completedNCT00757042What this trial is testingSafety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic DermatitisWho this might be right forAtopic DermatitisHealthy Volunteers Amgen 78
Early research (Phase 1)Study completedNCT06009094What this trial is testingSafety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Jiangsu vcare pharmaceutical technology co., LTD 80
Early research (Phase 1)UnknownNCT05843422What this trial is testingA First-in-Human Study of QY211 Gel in Adult SubjectsWho this might be right forAtopic Dermatitis E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 56
Early research (Phase 1)Study completedNCT05099133What this trial is testingA Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese SubjectsWho this might be right forAtopic Dermatitis LEO Pharma 24
Early research (Phase 1)Study completedNCT04544943What this trial is testingSafety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Hoth Therapeutics, Inc. 31
Early research (Phase 1)Study completedNCT00958516What this trial is testingAssessment of the Phototoxic Potential of LEO 29102 CreamWho this might be right forAtopic Dermatitis LEO Pharma 32
Not applicableStudy completedNCT05048121What this trial is testingRCT to Evaluate the Cosmetic Efficacy of Demo-cosmetic Active Ingredient CLS02021Who this might be right forOverall Skin AppearanceDry Skin; Eczema Anbiome Labs LLC 50